MetLife Investment Management’s MediciNova MNOV Stock Holding History

MetLife Investment Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-21,034	Closed	-$110K	–	2292
2020 Q3	$110K	Hold	21,034	–	–	﹤0.01%	2171
2020 Q2	$114K	Buy	+21,034	New	+$112K	﹤0.01%	2195
2020 Q1	–	Sell	-18,638	Closed	-$126K	–	2274
2019 Q4	$126K	Hold	18,638	–	–	﹤0.01%	2212
2019 Q3	$148K	Hold	18,638	–	–	﹤0.01%	2107
2019 Q2	$179K	Hold	18,638	–	–	﹤0.01%	2093
2019 Q1	$154K	Hold	18,638	–	–	﹤0.01%	2117
2018 Q4	$152K	Hold	18,638	–	–	﹤0.01%	2068
2018 Q3	$233K	Hold	18,638	–	–	﹤0.01%	2007
2018 Q2	$148K	Hold	18,638	–	–	﹤0.01%	2061
2018 Q1	$190K	Buy	+18,638	New	+$186K	﹤0.01%	1918

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MetLife Investment Management's MNOV Position: Q4 2020 in Review

MetLife Investment Management sold out of MediciNova (MNOV) in Q4 2020, closing a stake of 21,034 shares — an estimated $110K sold.

MetLife Investment Management first reported a position in MNOV in Q1 2018 and held it in 10 quarters. The position peaked at $233K in Q3 2018. 57 funds tracked by Wall St. Rank hold MNOV as of Q4 2020.

MetLife Investment Management reported no remaining MediciNova position as of Q4 2020 after selling out during the quarter.
MetLife Investment Management sold 21,034 MediciNova shares in Q4 2020, an estimated $110K.
MetLife Investment Management first reported a position in MediciNova in Q1 2018 and held it in 10 quarters.
MetLife Investment Management's MediciNova position peaked at $233K in Q3 2018.
57 funds tracked by Wall St. Rank held MediciNova as of Q4 2020.

Based on MetLife Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.